Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00684 | Pachyonychia congenita | Pachyonychia congenita (PC) is a group of autosomal dominant skin disorders characterized by hypertrophic nail dystrophy accompanied by other features of ectodermal dysplasia, prominently painful palmoplantar ... | Congenital malformation |
(PC1) KRT16 [HSA:3868] [KO:K07604] (PC2) KRT17 [HSA:3872] [KO:K07604] (PC3) KRT6A [HSA:3853] [KO:K07605] (PC4) KRT6B [HSA:3854] [KO:K07605] |
|
H00718 | Sotos syndrome | Overgrowth syndromes are a heterogeneous group of disorders resulting from the dysfunction of various processes involving cell proliferation, cell growth, or apoptosis. Within this group, Sotos syndrome ... | Congenital malformation |
(SOTOS1) NSD1 [HSA:64324] [KO:K15588] (SOTOS2) NFIX [HSA:4784] [KO:K09171] (SOTOS3) APC2 [HSA:10297] [KO:K02085] |
|
H00760 | Spondyloepiphyseal dysplasia tarda | X-linked spondyloepiphyseal dysplasia tarda is a rare osteochondrodysplasia characterized by disproportionately short stature with short trunk. The symptoms of this condition appear later in childhood ... | Congenital malformation | TRAPPC2 [HSA:6399] [KO:K20301] | |
H00768 |
Autosomal recessive intellectual developmental disorder Autosomal recessive mental retardation |
Intellectual developmental disorder, formerly known as Mental retardation (MR), is a neurodevelopmental disorder characterized by low intelligence quotient (IQ) and deficits in adaptive behaviors. To date ... | Mental and behavioural disorder |
(MRT1) PRSS12 [HSA:8492] [KO:K09624] (MRT2) CRBN [HSA:51185] [KO:K11793] (MRT3) CC2D1A [HSA:54862] [KO:K18260] (MRT5) NSUN2 [HSA:54888] [KO:K15335] (MRT6) GRIK2 [HSA:2898] [KO:K05202] (MRT7) TUSC3 [HSA:7991] [KO:K19478] (MRT12) ST3GAL3 [HSA:6487] [KO:K00781] (MRT13) TRAPPC9 [HSA:83696] [KO:K20306] (MRT14) TECR [HSA:9524] [KO:K10258] (MRT15) MAN1B1 [HSA:11253] [KO:K23741] (MRT18) MED23 [HSA:9439] [KO:K15166] (MRT27) LINS1 [HSA:55180] [KO:K22533] (MRT34) CRADD [HSA:8738] [KO:K02832] (MRT36) ADAT3 [HSA:113179] [KO:K15442] (MRT37) ANK3 [HSA:288] [KO:K09259] (MRT38) HERC2 [HSA:8924] [KO:K10595] (MRT39) TTI2 [HSA:80185] [KO:K23115] (MRT40) TAF2 [HSA:6873] [KO:K03128] (MRT41) KPTN [HSA:11133] [KO:K23295] (MRT42) PGAP1 [HSA:80055] [KO:K05294] (MRT43) WASHC4 [HSA:23325] [KO:K18465] (MRT44) METTL23 [HSA:124512] [KO:K23151] (MRT45) FBXO31 [HSA:79791] [KO:K10308] (MRT46) NDST1 [HSA:3340] [KO:K02576] (MRT47) FMN2 [HSA:56776] [KO:K02184] (MRT48) SLC6A17 [HSA:388662] [KO:K05048] (MRT49) GPT2 [HSA:84706] [KO:K00814] (MRT50) EDC3 [HSA:80153] [KO:K12615] (MRT51) HNMT [HSA:3176] [KO:K00546] (MRT52) LMAN2L [HSA:81562] [KO:K10083] (MRT53) PIGG [HSA:54872] [KO:K05310] (MRT54) TNIK [HSA:23043] [KO:K08840] (MRT55) PUS3 [HSA:83480] [KO:K01855] (MRT56) ZC3H14 [HSA:79882] [KO:K23038] (MRT57) MBOAT7 [HSA:79143] [KO:K13516] (MRT58) ELP2 [HSA:55250] [KO:K11374] (MRT59) IMPA1 [HSA:3612] [KO:K01092] (MRT60) TAF13 [HSA:6884] [KO:K03127] (MRT61) RUSC2 [HSA:9853] [KO:K23291] (MRT62) PIGC [HSA:5279] [KO:K03859] (MRT63) CAMK2A [HSA:815] [KO:K04515] (MRT64) LINGO1 [HSA:84894] [KO:K23533] (MRT65) KDM5B [HSA:10765] [KO:K11446] (MRT66) C12orf4 [HSA:57102] (MRT67) EIF3F [HSA:8665] [KO:K03249] (MRT68) TRMT1 [HSA:55621] [KO:K00555] (MRT69) ZBTB11 [HSA:27107] [KO:K10498] (MRT70) RSRC1 [HSA:51319] [KO:K24594] (MRT71) ALKBH8 [HSA:91801] [KO:K10770] (MRT72) METTL5 [HSA:29081] [KO:K24418] (MRT73) NAA20 [HSA:51126] [KO:K17972] (MRT74) APC2 [HSA:10297] [KO:K02085] (MRT75) PIDD1 [HSA:55367] [KO:K10130] (MRT76) GRIA1 [HSA:2890] [KO:K05197] (MRT77) CEP104 [HSA:9731] [KO:K16458] (MRT78) WDR11 [HSA:55717] [KO:K24260] (MRT79) TPR [HSA:7175] [KO:K09291] (MRT80) CASP2 [HSA:835] [KO:K02186] (MRT81) ASCC3 [HSA:10973] [KO:K18663] (MRT82) NSUN6 [HSA:221078] [KO:K21971] |
|
H00773 |
Autosomal dominant intellectual developmental disorder Autosomal dominant mental retardation |
Intellectual developmental disorder, formerly known as Mental retardation (MR), is a neurodevelopmental disorder characterized by low intelligence quotient (IQ) and deficits in adaptive behaviors. Most ... | Mental and behavioural disorder |
(MRD1) MBD5 [HSA:55777] [KO:K23219] (MRD2) DOCK8 [HSA:81704] [KO:K21852] (MRD3) CDH15 [HSA:1013] [KO:K06809] (MRD4) KIRREL3 [HSA:84623] [KO:K25874] (MRD5) SYNGAP1 [HSA:8831] [KO:K17631] (MRD6) GRIN2B [HSA:2904] [KO:K05210] (MRD7) DYRK1A [HSA:1859] [KO:K08825] (MRD8) GRIN1 [HSA:2902] [KO:K05208] (MRD9) KIF1A [HSA:547] [KO:K10392] (MRD10) CACNG2 [HSA:10369] [KO:K04867] (MRD11) EPB41L1 [HSA:2036] [KO:K23961] (MRD12) ARID1B [HSA:57492] [KO:K11653] (MRD13) DYNC1H1 [HSA:1778] [KO:K10413] (MRD14) ARID1A [HSA:8289] [KO:K11653] (MRD15) SMARCB1 [HSA:6598] [KO:K11648] (MRD16) SMARCA4 [HSA:6597] [KO:K11647] (MRD17) PACS1 [HSA:55690] [KO:K23290] (MRD18) GATAD2B [HSA:57459] [KO:K23194] (MRD19) CTNNB1 [HSA:1499] [KO:K02105] (MRD20) MEF2C [HSA:4208] [KO:K04454] (MRD21) CTCF [HSA:10664] [KO:K23195] (MRD22) ZBTB18 [HSA:10472] [KO:K23196] (MRD23) SETD5 [HSA:55209] [KO:K23216] (MRD24) DEAF1 [HSA:10522] [KO:K23041] (MRD25) AHDC1 [HSA:27245] [KO:K22592] (MRD26) AUTS2 [HSA:26053] [KO:K23214] (MRD27) SOX11 [HSA:6664] [KO:K09268] (MRD29) SETBP1 [HSA:26040] [KO:K23217] (MRD30) ZMYND11 [HSA:10771] [KO:K23218] (MRD31) PURA [HSA:5813] [KO:K21772] (MRD32) KAT6A [HSA:7994] [KO:K11305] (MRD33) DPP6 [HSA:1804] [KO:K23013] (MRD34) COL4A3BP [HSA:10087] [KO:K08283] (MRD35) PPP2R5D [HSA:5528] [KO:K11584] (MRD36) PPP2R1A [HSA:5518] [KO:K03456] (MRD38) EEF1A2 [HSA:1917] [KO:K03231] (MRD39) MYT1L [HSA:23040] [KO:K23193] (MRD40) CHAMP1 [HSA:283489] [KO:K22593] (MRD41) TBL1XR1 [HSA:79718] [KO:K04508] (MRD42) GNB1 [HSA:2782] [KO:K04536] (MRD43) HIVEP2 [HSA:3097] [KO:K09239] (MRD44/63) TRIO [HSA:7204] [KO:K08810] (MRD45) CIC [HSA:23152] [KO:K20225] (MRD46) KCNQ5 [HSA:56479] [KO:K04930] (MRD47) STAG1 [HSA:10274] [KO:K06671] (MRD48) RAC1 [HSA:5879] [KO:K04392] (MRD49) TRIP12 [HSA:9320] [KO:K10590] (MRD50) NAA15 [HSA:80155] [KO:K20792] (MRD51) KMT5B [HSA:51111] [KO:K11429] (MRD52) ASH1L [HSA:55870] [KO:K06101] (MRD53) CAMK2A [HSA:815] [KO:K04515] (MRD54) CAMK2B [HSA:816] [KO:K04515] (MRD55) NUS1 [HSA:116150] [KO:K19177] (MRD56) CLTC [HSA:1213] [KO:K04646] (MRD57) TLK2 [HSA:11011] [KO:K08864] (MRD58) SET [HSA:6418] [KO:K11290] (MRD59) CAMK2G [HSA:818] [KO:K04515] (MRD60) AP2M1 [HSA:1173] [KO:K11826] (MRD61) MED13 [HSA:9969] [KO:K15164] (MRD62) DLG4 [HSA:1742] [KO:K11828] (MRD64) ZNF292 [HSA:23036] [KO:K26728] (MRD65) KDM4B [HSA:23030] [KO:K06709] (MRD66) ATP2B1 [HSA:490] [KO:K05850] (MRD67) GRIA1 [HSA:2890] [KO:K05197] (MRD68) KMT2B [HSA:9757] [KO:K14959] (MRD69) LMAN2L [HSA:81562] [KO:K10083] (MRD70) SETD2 [HSA:29072] [KO:K11423] (MRD71) RFX7 [HSA:64864] [KO:K09175] (MRD72) SRRM2 [HSA:23524] [KO:K13172] (MRD73) TAF4 [HSA:6874] [KO:K03129] (MRD74) HNRNPC [HSA:3183] [KO:K12884] |
|
H00779 | Usher syndrome | Usher syndrome (USH) is a group of autosomal recessively inherited disorders characterized by deafness and vision loss. Three clinical types USH1, USH2, and USH3, are distinguished on the basis of severity ... | Nervous system disease |
(USH1B) MYO7A [HSA:4647] [KO:K10359] (USH1C) USH1C [HSA:10083] [KO:K21877] (USH1D/1DF) CDH23, USH1D [HSA:64072] [KO:K06813] (USH1F/1DF) PCDH15 [HSA:65217] [KO:K16500] (USH1G) USH1G [HSA:124590] [KO:K21878] (USH1J) CIB2 [HSA:10518] [KO:K23837] (USH1M) ESPN [HSA:83715] [KO:K24047] (USH2A) USH2A [HSA:7399] [KO:K19636] (USH2A/2C) PDZD7 [HSA:79955] [KO:K21882] (USH2B/2C) GPR98 [HSA:84059] [KO:K18263] (USH2D) WHRN [HSA:25861] [KO:K21879] (USH3A) CLRN1 [HSA:7401] [KO:K23841] (USH3B) HARS [HSA:3035] [KO:K01892] (USH4) ARSG [HSA:22901] [KO:K12381] |
|
H00786 | Hypotrichosis | Hypotrichosis (HYPT) is a non-syndromic hair loss that includes hereditary hypotrichosis simplex (HHS), localized autosomal recessive hypotrichosis (LAH), and Marie-Unna hereditary hypotrichosis (MUHH) ... | Skin disease |
(HYPT1) APCDD1 [HSA:147495] [KO:K25812] (HYPT2) CDSN [HSA:1041] [KO:K23457] (HYPT3) KRT74 [HSA:121391] [KO:K07605] (HYPT4) HRURF [HSA:120766137] (HYPT4/MUHH1) HR [HSA:55806] [KO:K00478] (HYPT5/MUHH2) EPS8L3 [HSA:79574] [KO:K17277] (HYPT6/LAH1) DSG4 [HSA:147409] [KO:K07599] (HYPT7/LAH2) LIPH [HSA:200879] [KO:K19404] (HYPT8/LAH3) LPAR6 [HSA:10161] [KO:K04273] (HYPT11) SNRPE [HSA:6635] [KO:K11097] (HYPT12) RPL21 [HSA:6144] [KO:K02889] (HYPT13) KRT71 [HSA:112802] [KO:K07605] (HYPT14) LSS [HSA:4047] [KO:K01852] (HYPT15) C3orf52 [HSA:79669] [KO:K26953] |
|
H00811 | Distal arthrogryposis | Distal arthrogryposis (DA) is a distinct group of syndromes with congenital contractures primarily involving the hands and feet, which often is associated with abnormal facies. To date, 10 different DA ... | Congenital malformation |
(DA1A, DA2B4) TPM2 [HSA:7169] [KO:K10374] (DA1B) MYBPC1 [HSA:4604] [KO:K12557] (DA1C) MYL11 [HSA:29895] [KO:K12758] (DA2A, DA2B3) MYH3 [HSA:4621] [KO:K24220] (DA2B1) TNNI2 [HSA:7136] [KO:K12043] (DA2B2) TNNT3 [HSA:7140] [KO:K12046] (DA3, DA5) PIEZO2 [HSA:63895] [KO:K22128] (DA5D) ECEL1 [HSA:9427] [KO:K09610] (DA7) MYH8 [HSA:4626] [KO:K24220] (DA9) FBN2 [HSA:2201] [KO:K23342] (DA11) MET [HSA:4233] [KO:K05099] (DA12) ADAMTS15 [HSA:170689] [KO:K08629] |
|
H00831 | Primary dystonia | Dystonias are a heterogeneous group of hyperkinetic movement disorders characterized by involuntary sustained muscle contractions that lead to abnormal postures and repetitive movements. Presently, 30 ... | Nervous system disease |
(DYT1) TOR1A [HSA:1861] [KO:K22990] (DYT2) HPCA [HSA:3208] [KO:K23846] (DYT3) TAF1 [HSA:6872] [KO:K03125] (DYT4) TUBB4A [HSA:10382] [KO:K07375] (DYT5) GCH1 [HSA:2643] [KO:K01495] (DYT6) THAP1 [HSA:55145] [KO:K23203] (DYT8) PNKD [HSA:25953] [KO:K23864] (DYT9) SLC2A1 [HSA:6513] [KO:K07299] (DYT10/EKD1) PRRT2 [HSA:112476] [KO:K23897] (DYT11) SGCE [HSA:8910] [KO:K27061] (DYT12) ATP1A3 [HSA:478] [KO:K01539] (DYT16) PRKRA [HSA:8575] [KO:K24540] (DYT22JO/AO) TSPOAP1 [HSA:9256] [KO:K19922] (DYT24) ANO3 [HSA:63982] [KO:K19498] (DYT25) GNAL [HSA:2774] [KO:K04633] (DYT26) KCTD17 [HSA:79734] [KO:K21914] (DYT27) COL6A3 [HSA:1293] [KO:K06238] (DYT28) KMT2B [HSA:9757] [KO:K14959] (DYT29/DYTOABG) MECR [HSA:51102] [KO:K07512] (DYT30) VPS16 [HSA:64601] [KO:K20180] (DYT31) AOPEP [HSA:84909] [KO:K09606] (DYT32) VPS11 [HSA:55823] [KO:K20179] (DYT33) EIF2AK2 [HSA:5610] [KO:K16195] (DYT34) KCNN2 [HSA:3781] [KO:K04943] (DYT35) SHQ1 [HSA:55164] [KO:K14764] (DYT36/EKD3) TMEM151A [HSA:256472] (DYT37) NUP54 [HSA:53371] [KO:K14308] |
|
H00865 | Lethal congenital contractural syndrome | Lethal congenital contractural syndrome (LCCS) is a heterogeneous group of disorders characterized by congenital nonprogressive joint contractures with a severe form of arthrogryposis. LCCS is inherited ... | Congenital malformation |
(LCCS1) GLE1 [HSA:2733] [KO:K18723] (LCCS2) ERBB3 [HSA:2065] [KO:K05084] (LCCS3) PIP5K1C [HSA:23396] [KO:K00889] (LCCS4) MYBPC1 [HSA:4604] [KO:K12557] (LCCS5) DNM2 [HSA:1785] [KO:K23484] (LCCS6) ZBTB42 [HSA:100128927] [KO:K23196] (LCCS7) CNTNAP1 [HSA:8506] [KO:K07379] (LCCS8) ADCY6 [HSA:112] [KO:K08046] (LCCS9) ADGRG6 [HSA:57211] [KO:K08463] (LCCS10) NEK9 [HSA:91754] [KO:K20878] (LCCS11) GLDN [HSA:342035] [KO:K16364] |
|
H00876 | Mismatch repair deficiency | ... mismatch repair mutations. MMR deficiency is correlated with hereditary non-polyposis colorectal cancer (HNPCC) and some forms of sporadic tumors. HNPCC also referred to as Lynch syndrome, is an autosomal-dominant-inherited ... | Cancer |
(MMRCS1/HNPCC2) MLH1 [HSA:4292] [KO:K08734] (MMRCS2/HNPCC1) MSH2 [HSA:4436] [KO:K08735] (MMRCS3/HNPCC5) MSH6 [HSA:2956] [KO:K08737] (MMRCS4/HNPCC4) PMS2 [HSA:5395] [KO:K10858] (HNPCC7) MLH3 [HSA:27030] [KO:K08739] |
|
H00897 | Pontocerebellar hypoplasia | Pontocerebellar hypoplasia (PCH) is a group of inherited progressive neurodegenerative disorders with prenatal onset. Up to now ten different subtypes have been reported. All subtypes share common characteristics ... | Congenital malformation |
(PCH1A) VRK1 [HSA:7443] [KO:K08816] (PCH1B) EXOSC3 [HSA:51010] [KO:K03681] (PCH1C) EXOSC8 [HSA:11340] [KO:K12586] (PCH1D) EXOSC9 [HSA:5393] [KO:K03678] (PCH1E) SLC25A46 [HSA:91137] [KO:K03454] (PCH1F) EXOSC1 [HSA:51013] [KO:K07573] (PCH2A/4/5) TSEN54 [HSA:283989] [KO:K15326] (PCH2B) TSEN2 [HSA:80746] [KO:K15322] (PCH2C) TSEN34 [HSA:79042] [KO:K15323] (PCH2D) SEPSECS [HSA:51091] [KO:K03341] (PCH2E) VPS53 [HSA:55275] [KO:K20299] (PCH2F) TSEN15 [HSA:116461] [KO:K15324] (PCH3) PCLO [HSA:27445] [KO:K16882] (PCH6) RARS2 [HSA:57038] [KO:K01887] (PCH7) TOE1 [HSA:114034] [KO:K13202] (PCH8) CHMP1A [HSA:5119] [KO:K12197] (PCH9) AMPD2 [HSA:271] [KO:K01490] (PCH10) CLP1 [HSA:10978] [KO:K14399] (PCH11) TBC1D23 [HSA:55773] [KO:K22555] (PCH12) COASY [HSA:80347] [KO:K02318] (PCH13) VPS51 [HSA:738] [KO:K20296] (PCH14) PPIL1 [HSA:51645] [KO:K12733] (PCH15) CDC40 [HSA:51362] [KO:K12816] (PCH16) MINPP1 [HSA:9562] [KO:K03103] (PCH17) PRDM13 [HSA:59336] [KO:K24645] |
|
H00939 |
Darsun syndrome Neutropenia, severe congenital 4, autosomal recessive G6PC3 deficiency |
G6PC3 deficiency is a syndromic variant of severe congenital neutropenia associated by complex organ malformation. Patients often have cardiac defects such as atrial septal defects, an increased superficial ... | Immune system disease | G6PC3 [HSA:92579] [KO:K01084] | |
H00961 | Posterior polymorphous corneal dystrophy | Posterior polymorphous corneal dystrophy (PPCD) is a very rare, bilateral autosomal dominant disorder affecting primarily the innermost corneal layers, Descemet membrane (DM), and the endothelium, biomicroscopically ... | Nervous system disease |
(PPCD1) OVOL2 [HSA:58495] [KO:K09216] (PPCD2) COL8A2 [HSA:1296] [KO:K23455] (PPCD3) ZEB1 [HSA:6935] [KO:K09299] (PPCD4) GRHL2 [HSA:79977] [KO:K09275] |
|
H00991 | Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II) | Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II) is an autosomal recessive condition characterized by severe intrauterine and postnatal growth failure, microcephaly, and disproportionate ... | Congenital malformation | PCNT [HSA:5116] [KO:K16481] | |
H01025 | Familial adenomatous polyposis | ... of the polyps. The genetic defect in FAP is a germline mutation in the adenomatous polyposis coli (APC) gene. In a subset of individuals, a MUTYH mutation causes a recessively inherited polyposis condition | Neoplasm |
(FAP1) APC [HSA:324] [KO:K02085] (FAP2) MUTYH [HSA:4595] [KO:K03575] (FAP3) NTHL1 [HSA:4913] [KO:K10773] (FAP4) MSH3 [HSA:4437] [KO:K08736] |
|
H01027 | Microphthalmia | Anophthalmia and/or microphthalmia (A/M) can be defined as an absence or reduced size of the globe in the orbit. Anophthalmia refers to complete absence of the globe in the presence of ocular adnexae. ... | Congenital malformation |
(MCOP2/MCOPCB3) VSX2 [HSA:338917] [KO:K09336] (MCOP4/MCOPCB6) GDF6 [HSA:392255] [KO:K20012] (MCOP5) MFRP [HSA:83552] [KO:K24359] (MCOP6) PRSS56 [HSA:646960] [KO:K23440] (MCOP7/MCOPCB6) GDF3 [HSA:9573] [KO:K22672] (MCOP8) ALDH1A3 [HSA:220] [KO:K07249] (MCOPCB5) SHH [HSA:6469] [KO:K11988] (MCOPCB7) ABCB6 [HSA:10058] [KO:K05661] (MCOPCB8) STRA6 [HSA:64220] [KO:K23088] (MCOPCB9) TENM3 [HSA:55714] [KO:K24473] (MCOPCB10) RBP4 [HSA:5950] [KO:K18271] (MCOPCB11) FZD5 [HSA:7855] [KO:K02375] |
|
H01036 | Posterior column ataxia with retinitis pigmentosa | Posterior column ataxia with retinitis pigmentosa (PCARP) is an autosomal recessive, childhood onset neurodegenerative disorder characterized by sensory ataxia and retinitis pigmentosa. It has been reported ... | Nervous system disease | FLVCR1 [HSA:28982] [KO:K08220] | |
H01039 | Ovarian hyperstimulation syndrome | ... the follicle-stimulating hormone receptor (FSHr) have been reported in these cases. Polycystic ovarian syndrome (PCOS) appears to be the major predisposing factor for OHSS in a large number of studies. | Reproductive system disease | FSHR [HSA:2492] [KO:K04247] | |
H01088 | Pigmented paravenous chorioretinal atrophy | Pigmented paravenous chorioretinal atrophy (PPCRA) is a rare retinal disorder characterized by the presence of bilaterally symmetrical chorioretinal atrophy, with accumulation of bone corpuscle pigmentation ... | Nervous system disease | CRB1 [HSA:23418] [KO:K16681] | |
H01111 | Cortisone reductase deficiency | ... phenotypic similarities between cortisone reductase deficiency (CRD) and polycystic ovary syndrome (PCOS). PCOS is a common endocrine disorder characterized by hirsutism, menstrual irregularity, anovulatory ... | Endocrine and metabolic disease |
(CORTRD1) H6PD [HSA:9563] [KO:K13937] (CORTRD2) HSD11B1 [HSA:3290] [KO:K15680] |
|
H01122 |
Congenital pulmonary alveolar proteinosis Pulmonary surfactant metabolism dysfunction |
Congenital pulmonary alveolar proteinosis is also known as pulmonary surfactant metabolism dysfunction (SMDP). It is caused by one of the three different genes associated with surfactant metabolism in ... | Respiratory system disease |
(SMDP1) SFTPB [HSA:6439] [KO:K26067] (SMDP2) SFTPC [HSA:6440] [KO:K26068] (SMDP3) ABCA3 [HSA:21] [KO:K05643] (SMDP4) CSF2RA [HSA:1438] [KO:K05066] (SMDP5) CSF2RB [HSA:1439] [KO:K04738] |
|
H01174 | Congenital diarrhea | Congenital diarrheas are a group of rare chronic enteropathies characterized by a heterogeneous etiology. In the first weeks of life, patients usually present with severe diarrhea that within a few hours ... | Digestive system disease |
(DIAR1) SLC26A3 [HSA:1811] [KO:K14078] (DIAR2/MVID1) MYO5B [HSA:4645] [KO:K10357] (DIAR3) SPINT2 [HSA:10653] [KO:K23421] (DIAR4) NEUROG3 [HSA:50674] [KO:K08028] (DIAR5) EPCAM [HSA:4072] [KO:K06737] (DIAR6) GUCY2C [HSA:2984] [KO:K12320] (DIAR7) DGAT1 [HSA:8694] [KO:K11155] (DIAR8) SLC9A3 [HSA:6550] [KO:K12040] (DIAR9) WNT2B [HSA:7482] [KO:K00182] (DIAR10) PLVAP [HSA:83483] [KO:K17309] (DIAR11) PERCC1 [HSA:105371045] (DIAR12/MVID2) STX3 [HSA:6809] [KO:K08486] (DIAR13) ACSL5 [HSA:51703] [KO:K01897] |
|
H01180 |
Sveinsson chorioretinal atrophy (SCRA) Helicoid peripapillary chorioretinal degeneration (HPCD) |
... chorioretinal atrophy (SCRA), also referred to as helicoid peripapillary chorioretinal degeneration (HPCD), is a distinct autosomal dominant disease affecting both eyes characterized clinically by bilateral ... | Nervous system disease | TEAD1 [HSA:7003] [KO:K09448] | |
H01203 |
Primary congenital glaucoma Glaucoma 3 |
Primary congenital glaucoma (PCG) is a severe form of glaucoma that presents early in life. PCG results from developmental abnormalities that affect the aqueous humor outflow pathway. PCG clinical features ... | Congenital malformation |
(GLC3A) CYP1B1 [HSA:1545] [KO:K07410] (GLC3D) LTBP2 [HSA:4053] [KO:K08023] (GLC3E) TEK [HSA:7010] [KO:K05121] |
|
H01215 | Simpson-Golabi-Behmel syndrome | ... of SGBS are type 1, that appear to arise as a result of either deletions or point mutations within the glypican-3 (GPC3) gene. SGBS type 2 is a severe variant, that is associated with defects in OFD1. | Congenital malformation |
(SGBS1) GPC3 [HSA:2719] [KO:K08109] (SGBS2) OFD1 [HSA:8481] [KO:K16480] |
|
H01216 | Left ventricular noncompaction | Left ventricular noncompaction (LVNC) is a rare and potentially progressive cardiomyopathy, characterized by the presence of prominent trabeculations of the left ventricle, associated with progressive ... | Cardiovascular disease |
(LVNC1) DTNA [HSA:1837] [KO:K26998] (LVNC3) LDB3 [HSA:11155] [KO:K19867] (LVNC4) ACTC1 [HSA:70] [KO:K12314] (LVNC5) MYH7 [HSA:4625] [KO:K17751] (LVNC6) TNNT2 [HSA:7139] [KO:K12045] (LVNC7) MIB1 [HSA:57534] [KO:K10645] (LVNC8) PRDM16 [HSA:63976] [KO:K22410] (LVNC9) TPM1 [HSA:7168] [KO:K10373] (LVNC10) MYBPC3 [HSA:4607] [KO:K12568] |
|
H01252 | Hereditary folate malabsorption | ... early, the signs and symptoms can be obviated by high oral doses of folates. Recently, several mutations were identified in the proton-coupled folate transporter (PCFT/SLC46A1) gene from patients with HFM. | Inherited metabolic disorder | SLC46A1 [HSA:113235] [KO:K14613] | |
H01263 |
Progressive cardiac conduction defect (PCCD) Progressive familial heart block (PFHB) Lenegre-Lev disease |
Progressive cardiac conduction defect (PCCD) is a cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system. It leads to complete atrioventricular ... | Cardiovascular disease |
(PFHB1A) SCN5A [HSA:6331] [KO:K04838] (PFHB1B) TRPM4 [HSA:54795] [KO:K04979] |
|
H01278 | Iron-refractory iron deficiency anemia | ... hypochromic microcytic anaemia, low transferrin saturation and high levels of the iron-regulated hormone hepcidin. The disease is caused by mutations in TMPRSS6, which encodes a type II transmembrane serine protease ... | Hematologic disease | TMPRSS6 [HSA:164656] [KO:K09637] | |
H01299 | Idiopathic pulmonary fibrosis | ... that presents in older adults with shortness of breath and cough. Mutations in surfactant protein C (SFTPC), surfactant protein A (SFTPA), telomerase reverse transcriptase (TERT), and telomerase RNA component ... | Respiratory system disease |
(PFBMFT1) TERT [HSA:7015] [KO:K11126] (PFBMFT2) TERC [HSA:7012] [KO:K22183] (ILD1) SFTPA1 [HSA:653509] [KO:K10067] (ILD2) SFTPA2 [HSA:729238] [KO:K10067] (ILD2) MUC5B [HSA:727897] [KO:K13908] SFTPC [HSA:6440] [KO:K26068] |
|
H01320 | Epidemic keratoconjunctivitis | ... well-defined adenoviral keratoconjunctivitis clinical syndromes: EKC and pharyngoconjunctival fever (PCF) [DS:H01420], which are caused by different HAdV serotypes. HAdV-8, HAdV-19, and HAdV-37 are common ... | Viral infectious disease | ||
H01348 | Mitochondrial phosphate carrier deficiency | Mitochondrial phosphate carrier deficiency (MPCD) is a novel disorder of oxidative phosphorylation caused by mutation in the SLC25A3 gene. The mitochondrial phosphate carrier SLC25A3 transports inorganic ... | Inherited metabolic disorder, Mitochondrial disease | SLC25A3 [HSA:5250] [KO:K15102] | |
H01400 | Secondary hyperammonemia | Hyperammonemia is a metabolic condition characterized by elevated levels of ammonia in the blood, and may result in irreversible brain damage if not treated early and thoroughly. Hyperammonemia can be ... | Inherited metabolic disorder |
MMUT [HSA:4594] [KO:K01847] PCCA [HSA:5095] [KO:K01965] PCCB [HSA:5096] [KO:K01966] IVD [HSA:3712] [KO:K00253] ACADM [HSA:34] [KO:K00249] ETFDH [HSA:2110] [KO:K00311] ETFA [HSA:2108] [KO:K03522] ETFB [HSA:2109] [KO:K03521] CPT2 [HSA:1376] [KO:K08766] SLC25A20 [HSA:788] [KO:K15109] SLC7A7 [HSA:9056] [KO:K13867] ALDH18A1 [HSA:5832] [KO:K12657] PC [HSA:5091] [KO:K01958] OAT [HSA:4942] [KO:K00819] CA5A [HSA:763] [KO:K01672] GLUD1 [HSA:2746] [KO:K00261] TMEM70 [HSA:54968] [KO:K17966] GLUL [HSA:2752] [KO:K01915] |
|
H01420 | Pharyngoconjunctival fever | Pharyngoconjunctival fever (PCF) is a syndrome attributed to human adenovirus B, particularly serotype 3, which causes small outbreaks, mainly among children. The syndrome may occur sporadically and can ... | Viral infectious disease | ||
H01428 | Xeroderma pigmentosum | Xeroderma pigmentosum (XP) is a rare autosomal-inherited, skin and neurodegenerative disease in which exposure to sunlight can result in a high incidence of skin and mucous membrane cancer. XP is classified ... | Congenital malformation |
(XPA) XPA [HSA:7507] [KO:K10847] (XPB) ERCC3 [HSA:2071] [KO:K10843] (XPC) XPC [HSA:7508] [KO:K10838] (XPD) ERCC2 [HSA:2068] [KO:K10844] (XPE) DDB2 [HSA:1643] [KO:K10140] (XPF) ERCC4 [HSA:2072] [KO:K10848] (XPG) ERCC5 [HSA:2073] [KO:K10846] (XPV) POLH [HSA:5429] [KO:K03509] |
|
H01521 |
Pneumocystis pneumonia Pneumocystis carinii pneumonia |
Pneumocystis pneumonia (PCP) is an infectious disease caused by Pneumocystis jirovecii that belongs to the genus Pneumocystis. Members of the genus Pneumocystis are unicellular, eukaryotic organisms that ... | Fungal infectious disease | ||
H01558 | Parathyroid carcinoma | Parathyroid carcinoma (PC) is a highly aggressive endocrine tumor, with an annual incidence of less than 1 per million. Over 90% of patients present with excess parathyroid hormone (PTH), representing ... | Cancer |
CDC73/HRPT2 (mutation) [HSA:79577] [KO:K15175] CASR [HSA:846] [KO:K04612] |
|
H01586 | Acquired pure red cell aplasia | ... consequent anaemia and reticulocytopenia in the presence of normal granulocytic and megakaryocytic lineages. RPCA can be classified into congenital and acquired. Congenital PRCA is also known as Diamond-Blackfan ... | Hematologic disease | ||
H01601 | Anaplastic large-cell lymphoma | ... strong expression of CD30. The World Health Organization recognizes 3 entities: primary cutaneous ALCL (pcALCL), anaplastic lymphoma kinase (ALK)-positive ALCL, and, provisionally, ALK-negative ALCL. pcALCL ... | Cancer |
NPM-ALK (translocation) [HSA:238] [KO:K05119] DUSP22-IRF4 (translocation) [HSA:56940] [KO:K14165] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |